Is BP a buy, hold, or sell?
BP carries a valuation grade of Strong Buy. The trailing P/E of 31.1 sits 159% above the Energy sector median of 12.0x — a premium that demands sustained earnings delivery. Our discounted cash flow model produces an intrinsic range of $46–$77 — implying a +60% margin of safety at the current price of $38.55. The width of the DCF range reflects genuine uncertainty in the terminal growth rate assumption: the correct framework is a probability-weighted distribution over scenarios, not a single point estimate. See the DCF valuation framework for full methodology.
With a 9% beat rate on recent quarters, earnings predictability has been mixed. The most recent quarter delivered a 33.2% earnings surprise. Analyst estimate revisions are trending upward.
What are BP's key risk factors?
With a beta of -0.23, BP exhibits a low-volatility risk profile relative to the broad market. The 95th-percentile CVaR of -14.3% on a one-month horizon should inform position sizing directly: at a 10% portfolio weight, this tail event contributes approximately 1.4% of total portfolio loss in the worst 5% of months. Net margins of 1.7% fall below the Energy sector average of 10%, suggesting margin pressure. The balance sheet is conservatively leveraged at 96% debt-to-equity.
At 0.56, the put/call ratio skews bullish, with call buyers dominating recent flow. Implied volatility of 38.6% exceeds realized volatility of 31.0% by 8 points, suggesting options are pricing in elevated risk. Short interest is low at 0.7% of float, suggesting limited bearish conviction.
How does BP fit in a diversified portfolio?
At typical HENRY portfolio weights — 10–20% of the equity allocation — BP carries a beta of -0.23, meaning it amplifies broad market moves proportionally. The appropriate weight is not a function of conviction alone, but of the full covariance structure across all holdings. See the Ledoit-Wolf covariance framework for the methodology behind these calculations.
Among closely correlated names, BP shows the strongest co-movement with SHEL (0.77), CVX (0.68), XOM (0.67). Investors seeking diversification should note these correlation dynamics when constructing multi-asset portfolios. With the top peer correlation at 0.77, adding BP to a portfolio that already holds these names provides limited marginal diversification benefit — particularly during stress events when correlations converge toward 1.0.
True portfolio risk is a function of the full covariance structure across all holdings — not individual stock metrics. The Portfolio Health Check quantifies this at the portfolio level: it surfaces hidden concentration, marginal CVaR contributions, and the degree to which your overall allocation deviates from an optimal risk-adjusted mandate. The BP analysis here is a single node in that larger structure.
For the portfolio construction framework underpinning BP’s position sizing and conviction rating — including IPS guardrails, Black-Litterman allocation, and CVaR constraints — see: Investment Policy Statement Framework →
